An antibody-platform company wanted to explore alternative business models as a means to generate additional revenue streams.
MSC was brought in to analyze the various business model opportunities that the client’s platform enabled. Based on a SWOT analysis of the client’s asset portfolio, a number of business opportunities were identified. These were subsequently ranked based on how each would affect company valuation, short vs long-term cash flow, investments in R&D and M&S, staffing requirements and other parameters. Spinouts, licensing, collaboration and additional commercial paths were considered as potential vehicles to achieve the different visions. A number workshops then defined the best business strategy based on the client’s internal resources, the management’s vision and MSC’s analysis. This resulted in a decision-support material to help the client’s board allocate resources towards implementing the best monetizing strategy.